相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The relative impact of psoriasis and obesity on socioeconomic and medical outcomes in psoriasis patients
G. E. Kim et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Systemic methotrexate therapy for psoriasis: past, present and future
S. Dogra et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2013)
OBSERVE-5 interim analysis: An observational postmarketing safety registry of etanercept for the treatment of psoriasis
Alexa B. Kimball et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies
C. Pouplard et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Psoriasis Severity and the Prevalence of Major Medical Comorbidity A Population-Based Study
Howa Yeung et al.
JAMA DERMATOLOGY (2013)
The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: A study from South India
Shraddha Madanagobalane et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2012)
Psoriasis Comorbidities: Results from the National Psoriasis Foundation Surveys 2003 to 2011
April W. Armstrong et al.
DERMATOLOGY (2012)
Psoriasis and metabolic syndrome
Hidetoshi Takahashi et al.
JOURNAL OF DERMATOLOGY (2012)
Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review
E. Archier et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies
A. W. Armstrong et al.
NUTRITION & DIABETES (2012)
Medical comorbidity associated with psoriasis in adults: a population-based study
Y-W. Yang et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
New IBD genetics: common pathways with other diseases
C. W. Lees et al.
GUT (2011)
Long-Term Prognosis and Comorbidities Associated with Psoriasis in the Newfoundland and Labrador Founder Population
Wayne P. Gulliver et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2011)
Psoriasis: depression, anxiety, smoking, and drinking habits
Jennifer Hayes et al.
DERMATOLOGIC THERAPY (2010)
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions
Batya B. Davidovici et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial
Richard G. Langley et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Comorbidities in Psoriasis Patients
Noori Kim et al.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2010)
Is there truly a risk of lymphoma from biologic therapies?
Erica Dommasch et al.
DERMATOLOGIC THERAPY (2009)
The AWARE Study: Methodology and Baseline Characteristics
Robert Bissonnette et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2009)
Psoriasis Comorbidities
Lyn Guenther et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2009)
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis
Luca Miele et al.
JOURNAL OF HEPATOLOGY (2009)
Psoriasis associated with ulcerative colitis and Crohn's disease
A. D. Cohen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Psoriasis and chronic obstructive pulmonary disease: a case-control study
J. Dreiher et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis
S. R. Feldman et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening
Alexa B. Kimball et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L. Leonardi et al.
LANCET (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
Kim A. Papp et al.
LANCET (2008)
Psoriasis 1 - Pathogenesis and clinical features of psoriasis
Christopher E. M. Griffiths et al.
LANCET (2007)
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Prevalence of cardiovascular risk factors in patients with psoriasis
Andrea L. Neimann et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Comorbidities in psoriasis
E. Christophers
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2006)
Psoriasis in Swedish conscripts:: time trend and association with T-helper 2-mediated disorders
E Landgren et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
S Tyring et al.
LANCET (2006)
Psoriasis therapy in real life: The need for registries
Marcus Schmitt-Egenolf
DERMATOLOGY (2006)
Relationship between smoking and the clinical severity of psoriasis
C Fortes et al.
ARCHIVES OF DERMATOLOGY (2005)
Current concepts - Basal-cell carcinoma.
AI Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
K Reich et al.
LANCET (2005)
The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study
CN Bernstein et al.
GASTROENTEROLOGY (2005)
A novel targeted T-cell modulator, efalizumab, for plaque psoriasis
M Lebwohl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Etanercept as monotherapy in patients with psoriasis
CL Leonardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Methodologic issues in observational studies
A Hartz et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2003)